GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

XBIO · Sep 30, 2024

Xenetic Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001683168-24-007903General Corporate
Operating cash generation93thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-74.73% · OPTIONAL · VALID

Revenue growth9thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

0.50% · CORE · VALID

Operating margin100thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.operating_margin

-81.32% · CORE · VALID

R&D intensity0thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

59.91% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

4.48% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History19 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-72.29%
Current
-74.73%
Delta
-2.44%
Growth Decreased
Previous
11.58%
Current
0.50%
Delta
-11.08%
Profitability Increased
Previous
-184.11%
Current
-81.32%
Delta
102.80%
R And D Intensity Decreased
Previous
128.55%
Current
59.91%
Delta
-68.64%
Sbc Intensity Decreased
Previous
5.80%
Current
4.48%
Delta
-1.31%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.